KRAS and Combined KRAS/TP53 Mutations in Locally Advanced Rectal Cancer are Independently Associated with Decreased Response to Neoadjuvant Therapy.

dc.contributor.author	BERGSLAND, E
dc.contributor.author	WEISER, MR
dc.contributor.author	BERGER, MF
dc.contributor.author	PATIL, S
dc.contributor.author	GARCIA-AGUILAR, J
dc.contributor.author	Keskin, Metin
dc.contributor.author	KUK, D
dc.contributor.author	CHOW, OS
dc.contributor.author	SMITH, JJ
dc.contributor.author	CAMACHO, N
dc.contributor.author	PELOSSOF, R
dc.contributor.author	CHEN, CT
dc.contributor.author	CHEN, Z
dc.contributor.author	AVILA, K
dc.date.accessioned	2021-03-03T10:45:05Z
dc.date.available	2021-03-03T10:45:05Z
dc.identifier.citation	CHOW O., KUK D., Keskin M., SMITH J., CAMACHO N., PELOSSOF R., CHEN C., CHEN Z., AVILA K., WEISER M., et al., "KRAS and Combined KRAS/TP53 Mutations in Locally Advanced Rectal Cancer are Independently Associated with Decreased Response to Neoadjuvant Therapy.", Annals of surgical oncology, cilt.23, ss.2548-55, 2016
dc.identifier.issn	1068-9265
dc.identifier.other	av_246033b7-52d4-416b-81a7-7eea4f311b59
dc.identifier.other	vv_1032021
dc.identifier.uri	http://hdl.handle.net/20.500.12627/29358
dc.identifier.uri	https://doi.org/10.1245/s10434-016-5205-4
dc.language.iso	eng
dc.title	KRAS and Combined KRAS/TP53 Mutations in Locally Advanced Rectal Cancer are Independently Associated with Decreased Response to Neoadjuvant Therapy.
dc.type	Makale
dc.relation.journal	Annals of surgical oncology
dc.contributor.department	, ,
dc.identifier.volume	23
dc.identifier.startpage	2548
dc.identifier.endpage	55
dc.contributor.firstauthorID	179330

Bu öğenin dosyaları:

Dosyalar	Boyut	Biçim	Göster
Bu öğe ile ilişkili dosya yok.